You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections
|
---|---|
Published in |
Journal of Translational Medicine, August 2019
|
DOI | 10.1186/s12967-019-2040-y |
Pubmed ID | |
Authors |
Susanna Esposito, Sonia Bianchini, Samantha Bosis, Claudia Tagliabue, Ilaria Coro, Alberto Argentiero, Nicola Principi |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Argentina | 2 | 18% |
Switzerland | 1 | 9% |
Russia | 1 | 9% |
Italy | 1 | 9% |
Unknown | 6 | 55% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 73% |
Scientists | 2 | 18% |
Practitioners (doctors, other healthcare professionals) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 80 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 11 | 14% |
Other | 10 | 13% |
Researcher | 8 | 10% |
Student > Master | 7 | 9% |
Professor > Associate Professor | 4 | 5% |
Other | 17 | 21% |
Unknown | 23 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 35% |
Immunology and Microbiology | 5 | 6% |
Biochemistry, Genetics and Molecular Biology | 5 | 6% |
Nursing and Health Professions | 4 | 5% |
Computer Science | 2 | 3% |
Other | 9 | 11% |
Unknown | 27 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2022.
All research outputs
#5,720,971
of 22,813,792 outputs
Outputs from Journal of Translational Medicine
#879
of 3,991 outputs
Outputs of similar age
#101,410
of 340,386 outputs
Outputs of similar age from Journal of Translational Medicine
#17
of 67 outputs
Altmetric has tracked 22,813,792 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 3,991 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,386 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.